BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2069598)

  • 1. Suppression of P450IIC12 gene expression and elevation of actin messenger ribonucleic acid levels in the livers of female rats after injection of the interferon inducer poly rI.poly rC.
    Morgan ET
    Biochem Pharmacol; 1991 Jun; 42(1):51-7. PubMed ID: 2069598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretranslational suppression of cytochrome P-450h (IIC11) gene expression in rat liver after administration of interferon inducers.
    Morgan ET; Norman CA
    Drug Metab Dispos; 1990; 18(5):649-53. PubMed ID: 1706245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cytochrome P450IIC12 expression by interleukin-1 alpha, interleukin-6, and dexamethasone.
    Wright K; Morgan ET
    Mol Pharmacol; 1991 Apr; 39(4):468-74. PubMed ID: 2017147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of constitutive cytochrome P-450 gene expression in livers of rats undergoing an acute phase response to endotoxin.
    Morgan ET
    Mol Pharmacol; 1989 Nov; 36(5):699-707. PubMed ID: 2511427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of hepatic drug metabolism by the interferon inducer, polyriboinosinic acid:polyribocitidylic acid.
    Sakai H; Okamoto T; Kikkawa Y
    J Pharmacol Exp Ther; 1992 Oct; 263(1):381-6. PubMed ID: 1403800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The suppression of hepatic cytochrome P4504A mRNA mediated by the interferon inducer polyinosinic acid.polycytidylic acid.
    Knickle LC; Spencer DF; Renton KW
    Biochem Pharmacol; 1992 Aug; 44(3):604-8. PubMed ID: 1380810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevention of acetaminophen-induced hepatotoxicity by the interferon inducer poly(rI . rC).
    Renton KW; Dickson G
    Toxicol Appl Pharmacol; 1984 Jan; 72(1):40-5. PubMed ID: 6710483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of rat hepatic CYP3A1 induction by the interferon inducer polyinosinic acid-polycytidylic acid (polyic).
    Delaporte E; Cribb AE; Renton KW
    Drug Metab Dispos; 1993; 21(3):520-3. PubMed ID: 7686458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of type I interferon-inducing agents on hepatic metallothionein.
    Bell JU; Lawman MJ; Lopez JM; DesJardin LE; Applewhite LA
    Experientia Suppl; 1987; 52():581-6. PubMed ID: 2959549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive effect of interferon inducer, polyriboinosinic acid-polyribocytidylic acid on induction of uridine diphosphate-glucuronyltransferases and monooxygenases in liver microsomes of rats.
    Matsunaga T; Nagata K; Hanioka N; Tanaka E; Buppodom P; Oguri K; Yoshimura H
    J Pharmacobiodyn; 1986 Apr; 9(4):421-7. PubMed ID: 3090228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of poly rI.rC and Newcastle disease virus on the expression of interferon and cellular genes in mouse cells.
    Kelley KA; Pitha PM
    Virology; 1985 Dec; 147(2):382-93. PubMed ID: 4071980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon induction by and toxicity of polyriboinosinic acid [poly(rI)].polyribocytidylic acid [poly (rC)], mismatched analog poly (rI).poly[r(C12Uracil)n], and poly(rI).poly(rC) L-lysine complexed with carboxymethylcellulose.
    Stringfellow DA; Weed SD
    Antimicrob Agents Chemother; 1980 Jun; 17(6):988-92. PubMed ID: 6157363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of co-administration of interferon inducer, polyriboinosinic acid-polyribocytidylic acid, with SKF 525-A on hepatic drug metabolizing enzymes of rats.
    Matsunaga T; Nagata K; Tanaka E; Oguri K; Yoshimura H
    J Pharmacobiodyn; 1986 Aug; 9(8):638-44. PubMed ID: 3097297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of two interferon-inducible human genes by interferon, poly(rI).poly(rC) and viruses.
    Wathelet MG; Clauss IM; Content J; Huez GA
    Eur J Biochem; 1988 Jun; 174(2):323-9. PubMed ID: 2454816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of interferon-inducible genes in mice by poly rI:rC or alloantigens.
    Gariglio M; Cinato E; Panico S; Cavallo G; Landolfo S
    J Immunother (1991); 1991 Feb; 10(1):20-7. PubMed ID: 1707309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the synthesis of hepatic cytochrome P-450 by the interferon-inducing agent poly rI.rCi.
    Singh G; Renton KW
    Can J Physiol Pharmacol; 1984 Apr; 62(4):379-83. PubMed ID: 6733584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the interferon inducing agents tilorone and polyriboinosinic acid . polyribocytidylic acid (poly IC) on the hepatic monooxygenase systems of pregnant and fetal rats.
    Robbins MS; Mannering GJ
    Biochem Pharmacol; 1984 Apr; 33(8):1213-22. PubMed ID: 6712731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone-dependent and -independent regulation of cytochrome P-450 isozyme expression in streptozotocin-diabetic rats.
    Donahue BS; Skottner-Lundin A; Morgan ET
    Endocrinology; 1991 Apr; 128(4):2065-76. PubMed ID: 1706265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression of cytochrome P450-dependent drug biotransformation by poly(rI.rC) and aspirin.
    Jagota SK
    Biochem Med Metab Biol; 1989 Jun; 41(3):212-6. PubMed ID: 2472829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of an interferon inducer, polyriboinosinic polyribocytidylic acid on cytochrome P-450 dependent hepatic progesterone metabolism.
    Wong JY; Lee EJ; Moochhala SM
    Life Sci; 1993; 53(25):1893-901. PubMed ID: 8255150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.